Osteotech Inc: Company Report
51 James Way
Eatontown NJ 07724
http://www.osteotech.com/ - Phone: 732-5422800
- Fax: 732-5429312
- Industry : Medical Instruments & Supplies
- Employees : 331
- Exchange : NASDAQ
Osteotech, Inc. (Osteotech) is a medical technology company that develops, processes and distributes biologic products focused on the orthopedic, neurosurgical and oral/maxillofacial surgery markets. The Company is focused on creating technology platforms that provides a variety of procedural specific biologic products to address the changing needs of orthopedics and healthcare in general. The Company’s products focus on biologic solutions for regenerative medicine that can alleviate pain, promote healing and restore functions. Osteotech has five technology platforms: Demineralized Bone Matrix (DBM), Hybrid/Synthetic, Human Collagen Technology, Traditional Tissue and Spinal Allograft.
| Stock Activity |
|---|
|
Last Price |
2.72 |
|
52 Week High |
5.04 |
|
52 Week Low |
1.31 |
|
Volume |
NA |
|
Average Daily Volume (13wk) |
47,970 |
|
50 Day Moving Average |
4.15 |
|
200 Day Moving Average |
3.95 |
|
Volatility (beta) |
0.75 |
| Stock Price History |
|---|
| | Change | Relative Strength |
|---|
| fyi |
Last 3 Months |
-37.6% |
8 |
|
Last 6 Months |
-27.1% |
13 |
| fyi |
Last 12 Months |
42.4% |
51 |
Historical charts
| Institutional Statistics |
|---|
| Analyst Consensus | Hold | | Institutional Ownership | 42.50% |
More Analyst Ratings
Want to learn how to evaluate a stock? Walk through the steps using the Research Wizard. | advertisement
| Financials |
|---|
| | Last 12 Months | 5 Year Growth |
|---|
|
Sales |
94.9 Mil |
1.9% |
|
Income |
-5.3 Mil |
-27.3% |
|
Dividend Rate |
0.00 |
NA |
|
Dividend Yield |
0.00% |
0.00% |
More financials
| Fundamental Data |
|---|
| Debt/Equity Ratio | 0.17 | | Gross Margin | 49.91% | | Net Profit Margin | -5.60% | | Total Shares Outstanding | 18.0 Mil | | Market Capitalization | 49.01 Mil | | Earnings/Share | -0.30 |
More financial ratios
| Earnings Estimates
|
|---|
| Qtr(12/09) EPS Estimate |
-0.06 |
| FY(12/09) EPS Estimate |
-0.34 |
| Current P/E |
NA |
| FY(12/10) EPS Estimate |
-0.04 |
| Forward P/E |
-68.00 |
| Next Earnings Release:
N/A | | More analyst estimates
|
Recent News